- Genedrive's PLC (LON: GDR) HepC test just entered the commercial phase as partner Sysmex launched in EMEA and APAC territories in recent weeks - Re-design of the mTB test in progress, launch date to be announced in the next fiscal year - Discussions for the disposal of the Services business entered an exclusivity period, expect an update by the end of June - Careful cash management with a £3.9mln cash balance at the end of February, we would expect a capital raise in the second half o
21 Mar 2018
Capital Network: Genedrive PLC - Interim Results for the six months to December 2017
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Capital Network: Genedrive PLC - Interim Results for the six months to December 2017
Genedrive Plc (GDR:LON) | 5.6 0 (-8.2%) | Mkt Cap: 8.05m
- Published:
21 Mar 2018 -
Author:
Dr. Riccardo Lowi -
Pages:
3
- Genedrive's PLC (LON: GDR) HepC test just entered the commercial phase as partner Sysmex launched in EMEA and APAC territories in recent weeks - Re-design of the mTB test in progress, launch date to be announced in the next fiscal year - Discussions for the disposal of the Services business entered an exclusivity period, expect an update by the end of June - Careful cash management with a £3.9mln cash balance at the end of February, we would expect a capital raise in the second half o